Non-Small Cell Lung Cancer Clinical Trial 2018-083

[LCID Study Number: 2018-083]

SWOG - Lung/MAP: A master protocol to evaluate biomarker-driven therapies and immunotherapies in previously-treated non-small cell lung cancer (lung-MAP screening study)

The purpose of this study is to find out if a targeted or immunotherapy treatment will have an effect on specific genes and proteins in your tumor.

Disease/Condition: Non-Small Cell Lung Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421

View NCT ID 03851445 on ClinicalTrials.gov
Protocol #: 2018-083
Principal Investigator(s): Brendan J. Connell
Study Coordinator(s): Julia Roache
Trial Phase: Sponsor Initiated Study Phase 3